Quantum BioPharma Ltd. (QNTM) Stock Forecast
QNTM analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 5.00 / 5 from 1 analysts
- Price target
- $12.34 average of analyst targets
- Upside to target
- +399.7% from the latest close
- Next earnings
- November 6, 2026
- 52-week range
- $2.10 – $14.67
QNTM analyst ratings
1 analystsNumber of analysts at each rating.
QNTM price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
QNTM earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.70 | −$0.70 | −$0.70 | −$1.77 | +60.5% | 1 |
| Current fiscal year (2026) | −$2.58 | −$2.58 | −$2.58 | −$11.35 | +77.3% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
QNTM revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0 | $0 | $0 | 0.0% | 1 |
| Current fiscal year (2026) | $0 | $0 | $0 | — | 1 |
| Next fiscal year (2027) | $0 | $0 | $0 | — | — |
QNTM EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
QNTM EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.00 | $0.00 | $0.00 | $0.00 | −$0.70 | — | 1 up · 0 down |
| Current fiscal year (2026) | $0.00 | $0.00 | $0.00 | $0.00 | −$2.58 | — | 0 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
QNTM earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; QNTM beat in 4 of 9.
What analysts expect from QNTM
1 analysts cover Quantum BioPharma; their consensus rating is strong buy (5.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $12.34, 399.7% above the latest close of $2.47. Analysts expect earnings of −$2.58 per share for 2026, +77.3% from a year earlier. Quantum BioPharma beat the EPS estimate in 4 of the last 9 quarters.
Related: QNTM income statement, QNTM key metrics, QNTM chart. See the QNTM stock overview for the latest quote and news.
QNTM forecast FAQ
What is Quantum BioPharma's price target?
The average analyst price target for Quantum BioPharma is $12.34, 399.7% above the latest close of $2.47.
Is Quantum BioPharma a buy, hold or sell?
Of 1 analysts covering Quantum BioPharma, 1 rate it a strong buy, 0 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Quantum BioPharma's EPS forecast?
Analysts forecast −$2.58 per share for 2026 (range −$2.58 to −$2.58).
When does Quantum BioPharma report earnings?
Quantum BioPharma is expected to report results for the quarter ending September 30, 2026 on November 6, 2026.
Does Quantum BioPharma usually beat earnings estimates?
Quantum BioPharma reported EPS at or above the analyst estimate in 4 of the last 9 quarters.